Wednesday, September 29, 2010

Frasers Centrepoint Trust

Frasers Centrepoint Trust: OCBC Research downgrades to Hold from Buy after recent run-up. Still likes FCT but valuations are looking less compelling. Keeps target price at $1.49. Recommends investors keen on exposure to Spore's retail market can consider Starhill Global, which it rates at Buy with $0.65 target. FCT offers DPU yield of 5.4% vs 6.7% for Starhill Global.

No comments:

Post a Comment